FDA’s Temple Pushes Feasibility, Cost-Savings Of Large, Simple Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
New tools and funding priorities support large, simple trials, now industry needs to get on board to create a more efficient, cost-effective health system, JAMA editorial says.